Superior Planning LLC’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding TRVI
Superior Planning LLC's TRVI Position: Q3 2026 in Review
Superior Planning LLC opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 17 shares worth $244. The stake represents ﹤0.01% of the portfolio and ranks #2016 among its holdings.
160 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.
- Superior Planning LLC held 17 shares of Trevi Therapeutics worth $244 as of Q3 2026.
- Trevi Therapeutics was a new Superior Planning LLC position in Q3 2026.
- Trevi Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #2016 holding.
- 160 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.